Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Ceres Prices IPO Of 5.0 Mln Shares At $13/Shr - Quick Facts

RELATED NEWS
Trade CERE now with 

Energy crop company Ceres Inc. (CERE: Quote) said it has priced its initial public offering of 5.0 million shares at $13.00 per share. The common stock may begin trading on the NASDAQ Global Market on February 22, 2012 under the ticker symbol "CERE." The underwriters have been granted a 30-day option to buy up to an additional 750,000 common shares from Ceres.

The offering may close on February 27, 2012, with all shares being offered by Ceres. Goldman, Sachs & Co. and Barclays Capital acted as joint book-running managers for the offering and Piper Jaffray, Raymond James and Simmons & Company International acted as co-managers

Click here to receive FREE breaking news email alerts for CERES, INC. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Specialty drugmaker Horizon Pharma plc (HZNP) on Friday managed to redomicile itself as an entity incorporated in Ireland following the completion of its $660 million acquisition of Vidara Therapeutics International plc. The deal will help it avoid paying the high rate of U.S. corporate taxes. The... Stocks showed a lack of direction over the course of the trading day on Friday after failing to sustain an initial upward move. Despite the choppy trading, the Dow once again managed to end the session at a new record closing high. The major averages turned in a mixed performance on the day. President Barack Obama delivered a statement Thursday evening thanking members of Congress for voting to approve legislation granting the U.S. military the authority to train and arm moderate Syrian rebels fighting against the terrorist group known as the Islamic State.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.